The WasteWatcher
The WasteWatcherThe Human Cost of Pharmaceutical Price Controls is Too High
Price controls will result in the loss of life due to a lack of future research and development.
The WasteWatcherHawaii Governor David Ige Approves $400 Million for Stadium Project
Hawaiians should keep watch on the project to ensure that the costs to taxpayers do not increase.
The WasteWatcherNorth Carolina Lawmakers Should Reject Proposed Taxpayer Subsidy for the ACC
State lawmakers should not allow the ACC to hold taxpayers hostage with demands for millions of dollars in subsidies.
The WasteWatcherGAO Report Outlines Waste in Unemployment Fraud Program
When the COVID-19 pandemic spread across the country, the federal government responded with a massive amount of money.
The WasteWatcherFederal Funding for Broadband Should Be Vendor and Technology Neutral
When planning infrastructure spending on broadband deployment, rules should be technology and vendor neutral.
The WasteWatcherPrice Controls Are Still Bad Medicine
Price controls on pharmaceuticals distort the medical marketplace and will not lower drug prices.
The WasteWatcherOnly Taxpayers Know What They Owe and the IRS Should Never File Anyone’s Taxes
Sen. Warren's proposal would vastly expand the size and scope of the IRS’s power.
The WasteWatcherThe Senate Must Reject Price Controls on Pharmaceuticals
Senators should reject price controls on pharmaceuticals; they will not lower prices and lead to fewer future cures.
The WasteWatcherThe Senate Should Not Implement Price Controls on Pharmaceuticals
Price controls on pharmaceuticals will not lower prices and will lead to fewer future cures.
The WasteWatcherLimiting Access to Tobacco Harm Reduction Products Harms Public Health
The FDA’s decision to stop Juul from selling e-cigarette products in the U.S. will harm public health.
The WasteWatcherGAO Report Reveals Significant Duplication and Overlap in Broadband Programs
A recent report from the Government Accountability Office lays out paths to reduce wasteful practices in broadband programs.
The WasteWatcherRegulating PBMs Will Not Lower Drug Costs
Increasing regulations on pharmacy benefit managers will not reduce the cost of pharmaceuticals.
